118 related articles for article (PubMed ID: 37783655)
1. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Pinto E; Pelizzaro F; Cardin R; Battistel M; Palano G; Bertellini F; Kitenge MP; Peserico G; Farinati F; Russo FP
Dig Liver Dis; 2024 May; 56(5):872-879. PubMed ID: 37783655
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serum HIF-1α change following transarterial chemoembolization in hepatocellular carcinoma.
Lin ZH; Jiang JR; Ma XK; Chen J; Li HP; Li X; Wu XY; Huang MS; Lin Q
Clin Exp Med; 2021 Feb; 21(1):109-120. PubMed ID: 33037574
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Jing Q; Jianyong L; Jiming Y; Shuren L; Rui W; Wei L
Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
[TBL] [Abstract][Full Text] [Related]
4. Serum HIF-1alpha and VEGF levels pre- and post-TACE in patients with primary liver cancer.
Jia ZZ; Jiang GM; Feng YL
Chin Med Sci J; 2011 Sep; 26(3):158-62. PubMed ID: 22207924
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of VEGF and HIF-1 α in Hepatocellular Carcinoma Patients Receiving Sorafenib Versus Metformin Sorafenib Combination.
El Shorbagy S; abuTaleb F; Labib HA; Ebian H; Harb OA; Mohammed MS; Rashied HA; Elbana KA; Haggag R
J Gastrointest Cancer; 2021 Mar; 52(1):269-279. PubMed ID: 32212089
[TBL] [Abstract][Full Text] [Related]
6. [Correlations between serum hypoxia inducible factor-1α, vascular endothelial growth factor and computed tomography perfusion imaging at pre-and post-TACE in patients with primary hepatic carcinoma].
Jia ZZ; Huang YQ; Feng YL; Jiang GM
Zhonghua Yi Xue Za Zhi; 2013 May; 93(19):1472-5. PubMed ID: 24029570
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients.
Farid K; Elalfy H; Abo El-Khair SM; Elgamal H; Besheer T; Elmokadem A; Shabana W; Abed S; Elegezy M; El-Khalek AA; El-Morsy A; Negm A; Elsamanoudy AZ; El Deek B; Amer T; El-Bendary M
Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1203-1214. PubMed ID: 32933325
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
9. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
10. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
11. Influence of preoperative transcatheter arterial chemoembolization on gene expression in the HIF-1α pathway in patients with hepatocellular carcinoma.
Xu W; Kwon JH; Moon YH; Kim YB; Yu YS; Lee N; Choi KY; Kim YS; Park YK; Kim BW; Wang HJ
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1507-15. PubMed ID: 24853275
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients.
Ranieri G; Ammendola M; Marech I; Laterza A; Abbate I; Oakley C; Vacca A; Sacco R; Gadaleta CD
World J Gastroenterol; 2015 May; 21(19):6018-25. PubMed ID: 26019468
[TBL] [Abstract][Full Text] [Related]
13. High serum levels of vascular endothelial growth factor predict poor response to transarterial chemoembolization in hepatocellular carcinoma: a prospective study.
Poon RT; Lau C; Yu WC; Fan ST; Wong J
Oncol Rep; 2004 May; 11(5):1077-84. PubMed ID: 15069550
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolization.
Kim SS; Cho HJ; Won JH; Bae JI; Kang DR; Lee JD; Shin SJ; Lee KM; Yoo BM; Kim JK; Lee JH; Ahn SJ; Park JH; Cho SW; Cheong JY
Cytokine; 2015 Dec; 76(2):449-457. PubMed ID: 26163999
[TBL] [Abstract][Full Text] [Related]
15. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients.
Shim JH; Park JW; Kim JH; An M; Kong SY; Nam BH; Choi JI; Kim HB; Lee WJ; Kim CM
Cancer Sci; 2008 Oct; 99(10):2037-44. PubMed ID: 19016764
[TBL] [Abstract][Full Text] [Related]
16. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
Ke Q; Xiang F; Xiao C; Huang Q; Liu X; Zeng Y; Wang L; Liu J
BMC Cancer; 2021 Oct; 21(1):1117. PubMed ID: 34663242
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.
He K; Yang Z; Liu X; Yang Y; Song W; Wang S; Chen Y
Curr Oncol; 2022 Dec; 30(1):476-491. PubMed ID: 36661687
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Lee YK; Kim SU; Kim DY; Ahn SH; Lee KH; Lee DY; Han KH; Chon CY; Park JY
BMC Cancer; 2013 Jan; 13():5. PubMed ID: 23282286
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival.
Huang GW; Yang LY; Lu WQ
World J Gastroenterol; 2005 Mar; 11(11):1705-8. PubMed ID: 15786555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
